Skip to main content

Table 4 Five-year overall survival

From: Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen

  Chemotherapy + Placebo Chemotherapy + Panagen [38] [24] [39]
Patients Survived patients % Patients Survived patients % Survival, % Survival, % Survival, %
I        100.0 92.1  
II 4 4 100 19 17 89 89.0 81.8  
III 8 4 50 25 21 84 80.8 58.0  
IV 3 0 0 7 2 29    
Total 15 8 53 51 40 78    40–70